Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients

NCT05745532 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

β-thalassemia

Interventions

BIOLOGICAL: β-globin restored autologous hematopoietic stem cells

Sponsor

Shenzhen Hemogen